Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10
Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10
坎託·菲茨傑拉德維持對AvePoint的增持,將目標股價提高至10美元
Cantor Fitzgerald analyst Brett Knoblauch maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $8 to $10.
坎託·菲茨傑拉德分析師佈雷特·諾布勞赫維持AvePoint(納斯達克股票代碼:AVPT)的增持,並將目標股價從8美元上調至10美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。